Showing 1 - 5 results of 5 for search 'Léa Bernard', query time: 0.04s Refine Results
  1. 1
    Donor Age and Non-Relapse Mortality: Study of Their Association after HLA-Matched Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome

    Donor Age and Non-Relapse Mortality: Study of Their Association after HLA-Matched Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndr... by Yasmine Kadri, Michelle Phan, Nadia Bambace, Léa Bernard, Sandra Cohen, Jean-Sébastien Delisle, Thomas Kiss, Sylvie Lachance, Denis-Claude Roy, Guy Sauvageau, Olivier Veilleux, Jean Roy, Imran Ahmad

    Published 2022-08-01
    Get full text
    Article
  2. 2
    A Phase II, Open-Label Study of Lenalidomide and Dexamethasone Followed by Donor Lymphocyte Infusions in Relapsed Multiple Myeloma Following Upfront Allogeneic Stem Cell Transplant

    A Phase II, Open-Label Study of Lenalidomide and Dexamethasone Followed by Donor Lymphocyte Infusions in Relapsed Multiple Myeloma Following Upfront Allogeneic Stem Cell Transplant by Richard LeBlanc, Stéphanie Thiant, Rafik Terra, Imran Ahmad, Jean-Sébastien Claveau, Nadia Bambace, Léa Bernard, Sandra Cohen, Jean-Sébastien Delisle, Silvy Lachance, Thomas Kiss, Denis-Claude Roy, Guy Sauvageau, Jean Roy

    Published 2024-11-01
    Get full text
    Article
  3. 3
    P1396: CD33-DELETED HEMATOPOIETIC STEM AND PROGENITOR CELLS DISPLAY NORMAL ENGRAFTMENT AFTER HEMATOPOIETIC CELL TRANSPLANT (HCT) AND TOLERATE POST-HCT GEMTUZUMAB OZOGAMICIN (GO) WITHOUT CYTOPENIAS

    P1396: CD33-DELETED HEMATOPOIETIC STEM AND PROGENITOR CELLS DISPLAY NORMAL ENGRAFTMENT AFTER HEMATOPOIETIC CELL TRANSPLANT (HCT) AND TOLERATE POST-HCT GEMTUZUMAB OZOGAMICIN (GO) WI... by Guenther Koehne, Benjamin Tomlinson, Hyung Suh, Divya Koura, Christina Cho, Nadia M Bambace, Léa Bernard, Nirali N Shah, Roland Walter, John Dipersio, Miguel-Angel Perales, Michael R Loken, Kyle Breitschwerdt, Sritama Nath, Glen Raffel, Brenda W Cooper

    Published 2023-08-01
    Get full text
    Article
  4. 4
    1423 Novel immunotherapy based on commensal-derived peptides to drive an effective CD8 T Cell response against selected tumor-associated antigens (TAAs)

    1423 Novel immunotherapy based on commensal-derived peptides to drive an effective CD8 T Cell response against selected tumor-associated antigens (TAAs) by Ana Maia, Stephen Ansell, Philippe Armand, Cécile Gouttefangeas, Jonathan W Friedberg, Alice Talpin, Jerome Kervevan, Lucie Aubergeon, Tifanny Mersceman Blanc, Diana Bachrouche, Chloé Ventujol, Léa Bernard, Amandine Manteau, Jose Villasboas, Antonello Pinto, Francesc Bosch, Ramon García-Sanz, Carlos Grande Garcia, Stephen D Smith, Luca Arcaini, Reid Merryman, Pier Zinzani, Christophe Bonny, Laurent Chene, Joao Gamelas Magalhaes

    Published 2023-11-01
    Article
  5. 5
    Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer

    Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer by Agostina Stradella, Francois Ghiringhelli, Ana Maia, Cécile Gouttefangeas, Ulrich Herrlinger, Maria Vieito, Ahmed Idbaih, Ghazaleh Tabatabai, Olivier Adotevi, Alice Talpin, Jennifer Martinez, Wolfgang Wick, Laura Boullerot, Jerome Kervevan, Lucie Aubergeon, Diana Bachrouche, Chloé Ventujol, Léa Bernard, Amandine Manteau, Christophe Bonny, Laurent Chene, Iris Mildenberger, Michael C Burger, Jean-Marie Carpier, Guillaume Kulakowski, Camille Gaal, Francesco Strozzi, Coline Billerey, Ludivine Amable, Tifanny Mersceman, Alexandrine Garnier, Càtia Oliveira, Carolina Calderon, Michaël Bonnet, Julie Noguerol, Karl Laviolette, Marine Malfroy, Gregoire Chevalier, Olivier Joffre, David A. Reardon, Joao Gamelas Magalhaes

    Published 2025-02-01
    Get full text
    Article

Search Tools: